308 related articles for article (PubMed ID: 33402163)
41. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.
Gascoyne RD; Aoun P; Wu D; Chhanabhai M; Skinnider BF; Greiner TC; Morris SW; Connors JM; Vose JM; Viswanatha DS; Coldman A; Weisenburger DD
Blood; 1999 Jun; 93(11):3913-21. PubMed ID: 10339500
[TBL] [Abstract][Full Text] [Related]
42. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
Lae ME; Ahmed I; Macon WR
Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
[TBL] [Abstract][Full Text] [Related]
43. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
44. CD30-positive anaplastic large cell lymphoma in childhood: expression of p80npm/alk and absence of Epstein-Barr virus.
Nakagawa A; Nakamura S; Ito M; Shiota M; Mori S; Suchi T
Mod Pathol; 1997 Mar; 10(3):210-5. PubMed ID: 9071728
[TBL] [Abstract][Full Text] [Related]
45. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
[TBL] [Abstract][Full Text] [Related]
46. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
47. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease.
Fan G; Kotylo P; Neiman RS; Braziel RM
Am J Clin Pathol; 2003 Feb; 119(2):199-204. PubMed ID: 12579989
[TBL] [Abstract][Full Text] [Related]
48. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Chang BH; Stork L; Fan G
Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
[TBL] [Abstract][Full Text] [Related]
49. Anaplastic large cell lymphoma: Report of two cases with rare patterns (carcinomatous and sarcomatous) in fine needle aspiration cytology and histopathology.
Das DK; Mallik MK; Ali AE; Khadom FA; John B; Al-Ayanti M
Diagn Cytopathol; 2020 Nov; 48(11):1115-1120. PubMed ID: 32491282
[TBL] [Abstract][Full Text] [Related]
50. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma.
Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q
Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080
[TBL] [Abstract][Full Text] [Related]
51. Characteristics And Outcomes Of Anaplastic Large Cell Lymphoma Patients-A Single Centre Experience.
Athar S; Siddiqui N; Hameed A
J Ayub Med Coll Abbottabad; 2017; 29(1):37-41. PubMed ID: 28712170
[TBL] [Abstract][Full Text] [Related]
52.
Qiu L; Tang G; Li S; Vega F; Lin P; Wang SA; Wang W; Iyer SP; Malpica L; Miranda RN; Konoplev S; Tang Z; Fang H; Medeiros LJ; Xu J
Haematologica; 2023 Jun; 108(6):1604-1615. PubMed ID: 36453104
[TBL] [Abstract][Full Text] [Related]
53. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
54. [Gastrointestinal ALK-positive anaplastic large cell lymphoma: a clinicopathological analysis of five cases].
Chen L; Ke ZY; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):785-790. PubMed ID: 37527981
[No Abstract] [Full Text] [Related]
55. Anaplastic large cell lymphoma: a single institution experience from India.
Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L
J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711
[TBL] [Abstract][Full Text] [Related]
56. Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.
Asano N; Suzuki R; Ohshima K; Kagami Y; Ishida F; Yoshino T; Ogawa H; Morishima Y; Nakamura S
Int J Hematol; 2010 Apr; 91(3):426-35. PubMed ID: 20217288
[TBL] [Abstract][Full Text] [Related]
57.
Jiang Y; Wang L; Zhou W; Gu J; Tian Y; Dong Y; Fu L; Wu HB
Cancer Imaging; 2020 Jan; 20(1):4. PubMed ID: 31924270
[TBL] [Abstract][Full Text] [Related]
58. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
[TBL] [Abstract][Full Text] [Related]
59. ALK-negative anaplastic large cell lymphoma with "Hodgkin-like" cytomorphology and nuclear expression of PAX5.
Fratoni S; Niscola P; Zhao XF; Larocca LM; Capalbo A; Fabbretti M; Bernardini L; Abruzzese E
Pathol Res Pract; 2020 Feb; 216(2):152724. PubMed ID: 31784094
[TBL] [Abstract][Full Text] [Related]
60. JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK - Anaplastic Large Cell Lymphomas : New Insights into Their Heterogeneity.
Wang JC; Zhong LH; Lin WQ; Zhang WF; Xi YF; Liu YP; Zhu Q; Liu W; Zhu WF; Chen YP; Chen G
Am J Surg Pathol; 2023 Jan; 47(1):55-64. PubMed ID: 36315833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
